http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10493050-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cff28a0a2cf2f9f02a0a63d5d902e563
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee9f11f9991cba4d2dd08468ab254549
publicationDate 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10493050-B2
titleOfInvention Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use
abstract A pharmacological composition for the treatment of bacterial and protozoal infections in a patient. The preferred pharmacological composition comprises a pharmaceutical carrier and an active composition selected from the group consisting of: a) an amount of sodium oxalate and an amount of oxalic acid, b) an amount of sodium citrate and an amount of citric acid, or c) mixtures of a) and b). The amounts and weight ratios of a) the sodium oxalate and oxalic acid, and b) the sodium citrate and citric acid in the active composition are such as to produce a safe and effective pharmacological composition. Sodium salts of other carboxylic acids may be used. The invention also relates to the method of using the pharmacological composition for the safe and effective treatment of bacterial infections, protozoal infections and dermatological diseases.
priorityDate 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6936579-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007027119-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7618658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6407141-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012269751-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012302642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012015809-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7883715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5639459-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5648389-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010292333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010234460-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6982097-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011152384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7517842-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007184016-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157934490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159119732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450229553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448617015

Total number of triples: 42.